Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Continuation Patent Application Allowed by USPTO

Premium

Benitec said this week that the US Patent and Trademark Office has issued a notice of allowance for one of the company's pending continuation patent applications derived from its core US patent.

The application, No. 20040064842, is "directed towards a double-stranded synthetic gene [that] comprises multiple copies of a structural gene region having a nucleotide sequence … identical to a nucleotide sequence of a target gene in a eukaryotic cell," Benitec said. "The multiple copies of a structural gene region are separated by a sequence of nucleotides that is 50 [to] 100 or 100 [to] 500 nucleotides in length."

The patent is derived from Benitec's key US patent, No. 6,573,099, which covers gene-expression knockdown using DNA that transcribes double-stranded RNA.

After the '099 patent fell under USPTO scrutiny as part of patent-infringement litigation the company initiated against now-defunct expressed RNAi shop Nucleonics, certain claims within the intellectual property were rejected by the patent office (see RNAi News, 1/21/2010).

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.